Counterpoint Mutual Funds LLC Buys Shares of 50,876 Nu Skin Enterprises, Inc. (NYSE:NUS)

Counterpoint Mutual Funds LLC bought a new stake in Nu Skin Enterprises, Inc. (NYSE:NUSFree Report) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 50,876 shares of the company’s stock, valued at approximately $704,000. Nu Skin Enterprises comprises approximately 0.2% of Counterpoint Mutual Funds LLC’s investment portfolio, making the stock its 12th biggest position. Counterpoint Mutual Funds LLC owned 0.10% of Nu Skin Enterprises as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Vanguard Group Inc. raised its position in shares of Nu Skin Enterprises by 0.9% during the third quarter. Vanguard Group Inc. now owns 6,235,495 shares of the company’s stock worth $132,255,000 after acquiring an additional 53,638 shares during the last quarter. Invesco Ltd. raised its position in shares of Nu Skin Enterprises by 91.8% during the third quarter. Invesco Ltd. now owns 1,694,112 shares of the company’s stock worth $35,932,000 after acquiring an additional 810,778 shares during the last quarter. Charles Schwab Investment Management Inc. raised its position in shares of Nu Skin Enterprises by 17.6% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,157,697 shares of the company’s stock worth $22,482,000 after acquiring an additional 173,193 shares during the last quarter. Norges Bank bought a new position in shares of Nu Skin Enterprises during the fourth quarter worth about $8,930,000. Finally, Federated Hermes Inc. raised its position in shares of Nu Skin Enterprises by 29,649.3% during the fourth quarter. Federated Hermes Inc. now owns 330,812 shares of the company’s stock worth $6,424,000 after acquiring an additional 329,700 shares during the last quarter. 82.84% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Separately, DA Davidson lowered their price objective on Nu Skin Enterprises from $15.50 to $12.50 and set a “neutral” rating for the company in a research report on Thursday, May 9th. Four research analysts have rated the stock with a hold rating, According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $20.83.

View Our Latest Stock Analysis on Nu Skin Enterprises

Insider Buying and Selling at Nu Skin Enterprises

In related news, Director Andrew D. Lipman sold 2,000 shares of Nu Skin Enterprises stock in a transaction that occurred on Tuesday, May 28th. The stock was sold at an average price of $13.33, for a total transaction of $26,660.00. Following the transaction, the director now owns 23,225 shares of the company’s stock, valued at $309,589.25. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Over the last quarter, insiders sold 5,693 shares of company stock valued at $71,690. Company insiders own 1.70% of the company’s stock.

Nu Skin Enterprises Trading Down 0.5 %

NUS stock traded down $0.05 during mid-day trading on Wednesday, reaching $10.65. The company’s stock had a trading volume of 863,834 shares, compared to its average volume of 767,551. The company has a market cap of $528.99 million, a price-to-earnings ratio of -177.47 and a beta of 1.16. The business’s 50 day moving average price is $12.78 and its 200 day moving average price is $14.74. The company has a current ratio of 2.09, a quick ratio of 1.24 and a debt-to-equity ratio of 0.56. Nu Skin Enterprises, Inc. has a 12 month low of $10.51 and a 12 month high of $34.31.

Nu Skin Enterprises (NYSE:NUSGet Free Report) last issued its earnings results on Wednesday, May 8th. The company reported $0.09 earnings per share for the quarter, topping analysts’ consensus estimates of $0.05 by $0.04. Nu Skin Enterprises had a positive return on equity of 9.28% and a negative net margin of 0.17%. The business had revenue of $417.31 million during the quarter, compared to the consensus estimate of $426.55 million. During the same period in the previous year, the company posted $0.37 earnings per share. The firm’s revenue for the quarter was down 13.3% on a year-over-year basis. On average, equities research analysts predict that Nu Skin Enterprises, Inc. will post 1.1 EPS for the current year.

Nu Skin Enterprises Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, June 12th. Shareholders of record on Friday, May 31st were paid a $0.06 dividend. The ex-dividend date of this dividend was Friday, May 31st. This represents a $0.24 dividend on an annualized basis and a yield of 2.25%. Nu Skin Enterprises’s dividend payout ratio (DPR) is presently -399.93%.

Nu Skin Enterprises Company Profile

(Free Report)

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.

Featured Articles

Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUSFree Report).

Institutional Ownership by Quarter for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.